Multibax Valuation
Is MBAX-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MBAX-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MBAX-R (THB2.84) is trading above our estimate of fair value (THB2.01)
Significantly Below Fair Value: MBAX-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MBAX-R?
Other financial metrics that can be useful for relative valuation.
What is MBAX-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿563.18m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1x |
Enterprise Value/EBITDA | 15.8x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MBAX-R's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.4x | ||
UBIS Ubis (Asia) | 0.6x | n/a | ฿564.3m |
WFX World Flex | 0.2x | n/a | ฿547.8m |
TPA Thai Poly Acrylic | 0.6x | n/a | ฿466.6m |
TRUBB Thai Rubber Latex Group | 0.1x | n/a | ฿850.5m |
MBAX-R Multibax | 0.5x | n/a | ฿563.2m |
Price-To-Sales vs Peers: MBAX-R is expensive based on its Price-To-Sales Ratio (0.5x) compared to the peer average (0.4x).
Price to Earnings Ratio vs Industry
How does MBAX-R's PE Ratio compare vs other companies in the TH Chemicals Industry?
Price-To-Sales vs Industry: MBAX-R is good value based on its Price-To-Sales Ratio (0.5x) compared to the TH Chemicals industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is MBAX-R's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.5x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate MBAX-R's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.